Diabetic tubulopathy: An emerging entity

Contributions to Nephrology

Volumn 170, Issue , 2011, Pages 124-134

  Tang, Sydney C W ^a   Leung, Joseph C K ^a   Lai, Kar Neng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; INTERCELLULAR ADHESION MOLECULE 1; TOLL LIKE RECEPTOR;

ANIMAL; ARTICLE; DIABETIC NEPHROPATHY; EPITHELIUM CELL; HUMAN; KIDNEY PROXIMAL TUBULE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY TUBULES, PROXIMAL; MAP KINASE SIGNALING SYSTEM; TOLL-LIKE RECEPTORS;

EID: 84925940565     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000325647     Document Type: Article

References (36)

1. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20: 1-17.
2. Benigni A, Zoja C, Remuzzi G: The renal toxicity of sustained glomerular protein traffic. Lab Invest 1995;73:461-468.
3. Eddy AA, McCulloch L, Liu E, Adams J: A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 1991;138:1111-1123.
4. Hemmelgarn BR, Manns BJ, Lloyd A et al: Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010;303: 423-429.
5. Zoja C, Morigi M, Figliuzzi M et al: Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995;26: 934-941.
6. Burton CJ, Combe C, Walls J, Harris KP: Fibronectin production by human tubular cells: The effect of apical protein. Kidney Int 1996;50:760-767. (Pubitemid 26302663)
7. Tang S, Sheerin NS, Zhou W, Brown Z, Sacks SH: Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells. J Am Soc Nephrol 1999;10:69-76. (Pubitemid 29034944)
8. Tang S, Lai KN, Chan TM, Lan HY, Ho SK, Sacks SH: Transferrin but not albumin mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. Am J Kidney Dis 2001;37:94-103. (Pubitemid 32055024)
9. Tang S, Leung JC, Abe K, et al: Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 2003;111:515-527. (Pubitemid 36228009)
10. Tang S, Leung JC, Tsang AW, Lan HY, Chan TM, Lai KN: Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: Implication on mechanism of tubuloglomerular communication in glomerulopathic proteinuria. Kidney Int 2002;61:1655-1665. (Pubitemid 34437919)
11. Wang Y, Chen J, Chen L, Tay YC, Rangan GK, Harris DC: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997;8:1537-1545. (Pubitemid 27496471)
12. Lai KN, Leung JC, Chan LY, Guo H, Tang SC: Interaction between proximal tubular epithelial cells and infiltrating monocytes/T cells in the proteinuric state. Kidney Int 2007;71:526-538. (Pubitemid 46402860)
13. Zoja C, Donadelli R, Colleoni S, et al: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 1998;53: 1608-1615. (Pubitemid 28243743)
14. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH: Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury. Kidney Int 2004;65:116-128. (Pubitemid 38037496)
15. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Kidney Int 1999;56:1627-1637. (Pubitemid 29518163)
16. Sanai T, Sobka T, Johnson T, et al: Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy. Diabetologia 2000;43:91-100. (Pubitemid 30129307)
17. Gugliucci A, Bendayan M: Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 1996;39: 149-160. (Pubitemid 26031025)
18. Youssef S, Nguyen DT, Soulis T, Panagiotopoulos S, Jerums G, Cooper ME: Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding. Kidney Int 1999;55: 907-916. (Pubitemid 29100702)
19. Tang SC, Leung JC, Chan LY, Tsang AW, Lai KN: Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist. J Am Soc Nephrol 2006;17:1633-1643. (Pubitemid 43794666)
20. Tashiro K, Koyanagi I, Saitoh A, et al: Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 2002;16: 1-4.
21. Wada T, Tomosugi N, Naito T, et al: Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis. J Exp Med 1994;180: 1135-1140. (Pubitemid 24256626)
22. Okada S, Shikata K, Matsuda M, et al: Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 2003;52: 2586-2593. (Pubitemid 37210549)
23. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH: Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 2005;16: 1711-1722. (Pubitemid 41716477)
24. Tang SC, Leung JC, Chan LY, Cheng AS, Lan HY, Lai KN: Renoprotection by rosiglitazone in accelerated type 2 diabetic nephropathy: Role of STAT1 inhibition and nephrin restoration. Am J Nephrol 2010;32: 145-155.
25. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Rollin BJ, Tesch GH: Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 2006;69:73-80. (Pubitemid 43117741)
26. Morcos M, Sayed AA, Bierhaus A, et al: Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 2002;51: 3532-3544. (Pubitemid 35403461)
27. Stenvinkel P, Ketteler M, Johnson RJ, et al: IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia -the good, the bad, and the ugly. Kidney Int 2005;67:1216-1233. (Pubitemid 40463099)
28. Tang SC, Chan LY, Leung JC, et al: Differential effects of AGEs on renal tubular inflammation. Nephrology 2010, Epub ahead of print.
29. Tang SC, Chan LY, Leung JC, et al: Bradykinin and high glucose promote renal tubular inflammation. Nephrol Dial Transplant 2010;25:698-710.
30. Dasu MR, Devaraj S, Park S, Jialal I: Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010;33: 861-868.
31. Lin M, Au WS, Chan LY, et al: Toll-like receptor 4 mediates high glucose-induced tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 2010;21:204A.
32. Li F, Yang N, Zhang L, et al: Increased expression of toll-like receptor 2 in rat diabetic nephropathy. Am J Nephrol 2010;32: 179-186.
33. Qi W, Chen X, Gilbert RE, et al: High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1. Am J Pathol 2007;171: 744-754. (Pubitemid 47440974)
34. Holian J, Qi W, Kelly DJ, et al: The Role of Kruppel-like factor 6 in transforming growth factor-beta-1-induced epithelialmesenchymal transition of proximal tubule cells. Am J Physiol Renal Physiol 2008;295: F1388-F1396.
35. Qi W, Chen X, Holian J, Tan CY, Kelly DJ, Pollock CA. Transcription factors Kruppellike factor 6 and peroxisome proliferatoractivated receptor-gamma mediate high glucose-induced thioredoxin-interacting protein. Am J Pathol 2009;175:1858-1867.
36. Qi W, Holian J, Tan CY, Kelly DJ, Chen XM, Pollock CA: The roles of Kruppel-like factor 6 and peroxisome proliferator-activated receptor-gamma in the regulation of macrophage inflammatory protein-3alpha at early onset of diabetes. Int J Biochem Cell Biol 2011;43:383-392.